The company said Oligomannate will be available in China "very soon," and it is currently seeking approval to market it abroad, with plans to launch third-phase clinical trials in the US and Europe in early 2020.
该公司表示甘露特钠胶囊将会“很快”在中国上市，目前正寻求批准在国外销售，并计划于2020年初在美国和欧洲启动第三阶段临床试验。
China approves seaweed-based Alzheimer's drug. It's the first new one in 17 years Via CNN
目前全球约有5000万阿尔兹海默患者，中国患者约占20%。阿尔茨海默病是以1906年发现这种疾病的神经病理学家Alois Alzheimer的名字命名的。到目前为止，世界范围内制药公司的研究进展缓慢。
In October, US pharmaceutical giant Biogen said it would pursue Food and Drug Administration (FDA) approval for an experimental treatment called aducanumab, after announcing in March it was canceling a large clinical trial for the drug.
美国制药巨头百健公司也在研发一种叫aducanumab的阿尔茨海默病治疗药物。继3月宣布将临床试验后不理想后，今年10月，百健公司宣布实验获得进展，将寻求美国食品和药物管理局(FDA)获批新药。
Johnson & Johnson, Merck, Pfizer and Eli Lilly have all previously abandoned projects to develop a drug for Alzheimer's after unsatisfactory clinical data.
此前由于临床数据不理想，强生、默克、辉瑞和礼来等公司都放弃了阿尔茨海默病药物的研发项目。
China approves seaweed-based Alzheimer's drug. It's the first new one in 17 years Via CNN
外国网友纷纷为中国科研人员的创新成果点赞：
Ok American doctors stay looking into it. Remember some of our medicines they discovered first.
好吧，美国的医生看看。记得有些药是他们(中国)先研制的。
Thousands of attempts have resulted on this drug. Hopefully, it will cure the patient in an expected way.
无数次努力尝试才有了这款新药的诞生，希望可以对患者有效。
Amazing! So what have we been doing? Of course big pharmaceutical wants to make every penny from the sick.
太棒了!所以看看我们做了些啥?各大医药公司只想着从患者身上赚取更多的钱。
图文：CNN，Twitter, 每日经济新闻
责编：王怡
版权作品，未经环球网 huanqiu.com 书面授权，严禁转载，违者将被追究法律责任。
,
